(A) Denaturing 1% agarose gel of full length T7 in vitro transcribed VEE-RF RNAs (~14,000 nts) stained with ethidium bromide. (B) B18R mRNA co-transfection with VEE-GFP RNA replicon enables GFP expression on day 1. (C) Immunoblot of B18R expressed from HFFs transfected with B18R mRNA, left side purified from conditioned media (CM) and right side amount present in condition media. (D) B18R must be present during VEE-GFP RNA transfection for optimal GFP expression. HFF cells were transfected with VEE-GFP RNA plus either B18R mRNA, recombinant B18R protein (rB18R, eBioscience) or B18R-Conditioned Media (B18R-CM) at the time of transfection or were treated with recombinant rB18R protein or B18R-CM 3 hr posttransfection, and then assayed for GFP expression levels by FACS on day 1. Error Bars represent the standard deviation of duplicate samples from one of two representative experiments. (E) Dose dependency of B18R Conditioned Media for persistent existence of VEE RNA replicon. Data shows day 7 post-transfection of VEE-GFP RNA. (A) Repeated transfection of VEE RNA increases the number of surviving cells to puromycin selection. HFFs were co-transfected with VEE-OKS-iM Plus B18R-mRNA on day 1 or day 1 and day 4. Bar, 500 µm. (B) Protein expression of RFs on day 10 after 2x (d1 and 3) or 5x (d1, 3, 5, 7 and 9) transfections and puromycin selection, as indicated. (C) B18R-CM is required for generation of iPS cells in feeder culture. HFFs were co-transfected with OKS-iM RNA and B18R mRNA, and then cultured in the presence of B18R-CM and puromycin. Cells were passaged to STO feeder cells on day 10 (d1, 3, 8 transfections) or day 11 (d1, 4, 7, 10 transfections), and cultured in the presence or absence of B18R-CM plus/minus puromycin. IPS cell colonies were stained for Akaline Phosphatase on day 25. -*: HFF conditioned medium was used instead of B18R-CM. (D) Oct4 and Sox2 immunoblot analysis of day 9 post a single transfection of HFF or BJ fibroblasts with T7-OKS-iM or infected with four retroviruses, as indicated. Hues9, HFF, BJ and mocked treated controls also shown. 
Movie S1. Spontaneous contractility of iPS cells differentiated into cardiomyocytes, related to Figure 5.
Embryoid bodies (EBs) were differentiated into cardiomyocytes at normoxia and video recordings were taken at day 15, approximately one week after the onset of spontaneous contractility. BJ and HFF cells were co-transfected with RNA replicon and B18R mRNA (3:1 ratio) into a starting well of 4 x 10 5 cells, then cultured in B18R-CM (conditioned medium) plus/minus puromycin. Generated iPS colonies were stained for Akaline phosphatase (AP+). Table S3 ), IRES and Puromycin resistance gene from pCX4puro (Akagi et al., 2003) . This vector was renamed as pVEE-IRES-Puro for our convenience.
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B18R mRNA synthesis
pTNT-B18R plasmid and pTNT-B18R-6His plasmid (6His-Tag at c-terminus of B18R) were used for the synthesis of B18R mRNA and B18R-6His mRNA, respectively. The pTNT vector contains a 5' -globin leader sequence and a synthetic poly (A) tail (30 bases) to enhance the expression of genes. 30 bases of poly(A) were not enough to stabilize mRNA, so additional poly(A) tail was added by poly(A) tail polymerase (see below). B18R-mRNA and B18R-6His mRNA synthesis were performed with modified nucleotides using the RiboMAX Large Scale 
Preparation of B18R conditioned medium (B18R-CM)
25% double modified B18R mRNA or B18R-6His mRNA (1 g for 1 well of 6-well plate, or 6 g for 10 cm dish) was transfected into HFFs with Lipofectamine 2000 (Invitrogen). After 3 hr, cells were cultured in Advanced DMEM (Invitrogen) containing 15% FCS (ES cell qualified, Millipore), penicillin, and streptomycin, or ES culture medium. Culture medium was collected on next day, filtrated, and stored at -20 C, or diluted 5 times with cell culture medium to generate 20%
B18R-CM. The activity of B18R-CM was briefly measured by the efficiency of repeated transfection of mRNAs. No difference was observed between B18R-CM from B18R-mRNA and B18R-6His mRNA transfection.
B18R-6His purification
HFFs were transfected with B18R-6His mRNAs and then collected conditioned medium (CM) on next day. CM was diluted with 6M GuHCl (final 4M GuHCl), and then purified with Ni-NTA agarose (Qiagen) according to manufacture's protocol. Purified B18R-6His protein amount was calculated with ChemiDoc System (BioRad) using BSA as a standard. Western blotting with anti-His tag (MBL, PM032) was performed for the estimation of B18R protein level in conditioned medium.
iPS generation by replicon transfection
Human finbroblasts were passaged to a 6-well plate on day-0 and cultured to ~90-100% confluency (4 x10 5 cells/well) on day-1. 1 g RNA mixture (3:1 ratio VEE RNA Replicon to B18R mRNA) was transfected with Lipofectamine 2000. 25% double modified B18-mRNA or 100% Psi modified mRNA were used for co-transfection. After 3 hr, transfection medium was changed to the Advanced DMEM (Invitrogen) or Pluriton (StemGent) containing 15% FCS (ES cell qualified, Millipore), penicillin, and streptomycin. Cells were cultured in medium containing B18R-CM and puromycin (0.8 g/ml) from day-2. Medium was changed everyday and transfections were performed every 3 days (day-1, 4, 7, 10). ES medium was used from day-7.
Puromycin was removed at day-7 (or day-10). One day after the final transfection, cells were passaged to STO feeder and cultured in ES medium containing B18R-CM. ES medium was changed everyday and cultured until iPS cell colonies were generated. Colonies were mechanically picked for isolation of clones or stained with Alkaline Phosphase Detection kit (Millipore) or manually prepared AP-staining solution containing 1 mg/ml of FastRed TR (Sigma) and 0.4 mg/ml of 1-Naphthyl phosphate (Sigma) in AP buffer (100 mM Tris, 100 mM NaCl and 50 mM MgCl 2 , pH 9.5)
RT-PCR for the detection of RNA replicon
Total RNAs were isolated with RNeasy mini kit ( C for 30 sec; followed by 72 C for 5 min. Primers used for RT-PCR are described in Supplementary Table S3 .
TaqMan RT-PCR
Total RNAs from feeder free culture of iPSCs clones, HUES-9, BJ and HFFs were isolated with RNeasy mini kit. TaqMan RT-PCR reactions were carried out using RNA-to-Ct one-step reaction (Applied Biosystem) according to manufacturer's protocol. 10 ng of total RNA were used per reaction. Primers and probes were obtained from AB TaqMan Gene Expression Assay catalog (GAPDH, Hs99999905_m1; POU5F1 Hs03005111_g1; Sox2 Hs01053049_s1; DNMT3B Hs00171876_m1; TERT Hs00972656_m1; Lin28 Hs00702808_s1; Nanog Hs02387400_g1; TDGF1 Hs02339499_g1). Quantitative PCR reactions were carried out in triplicate, and conditions were as followed: 20 min 55 C, 10 min 95 C, 40 cycles of 95 C for 0.15 min, 65 C for 1 min. Data were analyzed on the 7300 real-time PCR system (Applied Biosystems) using the delta-delta Ct method.
Southern Blotting
Genomic DNA was purified with several times extraction of Phenol/Chloroform/Isoamylalchol 
Genomic PCR analysis
PCRs for nsP2 region and Klf4 region were performed with the same program in RT-PCR for RNA-replicon check. 500 ng of genomic DNA was used for PCR. Primers were described in Supplementary Table 3 .
Differentiation of iPSCs to Cardiomyocytes
Prior to differentiation, hiPSC colonies were maintained on irradiated Mouse Embryonic Fibroblasts (MEFs) and grown to 50-80% confluency. hiPSCs were differentiated into cardiomyocytes as previously described with minor modifications (Yang et al. 2008) . In brief, embryoid bodies (EBs) were differentiated into cardiomyocytes at normoxia in Stempro34 media (Life Technologies #10639-011) by the addition of 1 ng/ml BMP4 (days 0-1), 10 ng/ml BMP4, 2.5 ng/ml bFGF, 3 ng/ml activin A (days 1-4), 5 ng/ml VEGF, 75 ng/ml DKK1 (days 4-8), 5 ng/ml VEGF, 75 ng/ml DKK1, 2.5 ng/ml bFGF (days 8-12), and 5 ng/ml VEGF (days 12-16). Video recordings were taken at day 15, approximately one week after the onset of spontaneous contractility. At day 16 spontaneously contractile EBs were dissociated using TrypLE Express and GFAP (neuronal cells) were used for markers of ectoderm, Desmin (muscle cells) for marker of mesoderm, and AFP (primitive and definitive endoderm) for marker of endoderm.
Immunofluorescence staining
Cells were washed twice in PBS and fixed in 4% paraformaldehyde for 10 min. Washed cells were treated with 0.1% Triton X-100 in PBS for 10 min. Cells were blocked with 2% BSA for 1hr at room temperature (RT), and then incubated with primary antibodies in PBS at 4 C overnight.
Cells were washed and incubated with secondary antibodies followed by incubation with DAPI or Hoechst 33342, and then washed and stored in PBS. Primary antibodies such as rabbit antiOct4, goat anti-Nanog and anti-Sox2, mouse anti-SSEA4, anti-Tra-1-60 and anti-Tra-1-81
antibodies were used at 1:100 to 1:500 dilutions. Alexa Fluor 488 (BD Biosciences) secondary antibodies were used at 1:800 dilutions.
